CADL: Candel Therapeutics Narx-foyda va o‘sish multiplikatori
EPS dinamikasiga nisbatan P/E koeffitsiyenti Candel Therapeutics (CADL) kompaniyasining bozor qiymatini ko'rsatadi, bunda 0.00 ko'rsatkichning yangi qiymatiga aylanadi. Candel Therapeutics xavfli hujayralarni shaxsiylashtirilgan vaksinalarga aylantiruvchi viral immunoterapiyalarni ishlab chiqadi. O'sish CAN-2409 platformasi va FDA Fast Track maqomlari hisobiga ta'minlanmoqda. Investorlarning yuqori ishonchi prostata va oshqozon osti bezi saratoni davolash bo'yicha muvaffaqiyatli klinik sinovlar bilan tasdiqlangan.
Candel Therapeutics (CADL) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Candel Therapeutics|CADL - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati candeltx.com|CADL - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Candel|CADL - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Candel Therapeutics|Shoshilinch likvidlik koeffitsiyenti candeltx.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
CADL - Sof foyda|Kutilayotgan sof foyda Candel Therapeutics|CADL - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati candeltx.com|CADL - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Candel|CADL - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Candel Therapeutics|CADL - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi candeltx.com|CADL - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Candel Therapeutics
Kompaniyaning umumiy tahlili:CADL Candel Therapeutics Inc.
Ushbu ko'rsatkich kompaniyaning bozor qiymatini uning foyda dinamikasi bilan solishtiradi, bu esa o'sish sur'atlari joriy P/E ko'paytirgichidan yuqori bo'lgan past baholangan aktivlarni aniqlash imkonini beradi. PEG koeffitsiyentini tahlil qilish orqali investor Candel Therapeutics (CADL) kompaniyasining kengayish potentsialini baholaydi, bunda platformaning qiymati chakana savdo sotuvlariga emas, balki FDA tasdig'iga va shifoxonalardagi klinik sinovlar natijalariga bog'liqdir.
Candel Therapeutics raqobatchilari
ONC (BeiGene Ltd.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HALO (Halozyme Inc.)|RVMD - Narx-foyda va o‘sish multiplikatori|AAPG: Narx-foyda va o‘sish multiplikatori|CGON - PEG multiplikatori|UroGen Pharma (URGN) - Narxning foydaga va o‘sish sur’atiga nisbati|Bicara Therapeutics Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PSNL (Personalis Corp) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Erasca Oncology ERAS|PEG multiplikatori DCTH|Narx-foyda va o‘sish multiplikatori ymabs.com YMAB|PEG multiplikatori AURA (Aura Biosciences)|PEG multiplikatori Accuray Inc ARAY|SLS - Narxning foydaga va o‘sish sur’atiga nisbati|ACTU (Actuate Therapeutics Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|CTOR: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti HURA|TARA (Protara Therapeutics, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Fate Therapeutics Inc FATE|Narxning foydaga va o‘sish sur’atiga nisbati Aadi Bioscience Inc (WHWK)|Narxning foydaga va o‘sish sur’atiga nisbati TCRX (tscan.com)|Champions Oncology, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XBIT|CVM: Narx-foyda va o‘sish multiplikatori|OS Therapies Inc. - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|RADX: PEG multiplikatori|Artiva Biotherapeutics - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ANL (Adlai Nortye Ltd) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda verupharma.com VERU|Narxning foydaga va o‘sish sur’atiga nisbati Tempest Therapeutics, Inc. (TPST)|XLO (xiliotx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori RENB (Renovaro)|PEG multiplikatori Mural Oncology PLC MURA|KAPA - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati OKUR|GDTC: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Curis (CRIS)|Narx-foyda va o‘sish multiplikatori APLM|PEG multiplikatori Tharimmune Corporation|Narx-foyda va o‘sish multiplikatori ADVB (Advanced Biomed Inc)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati GNPX|PEG multiplikatori CLDI (Calidi Biotherapeutics, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Sunshine Biopharma Inc. (SBFM)|Xenetic Bio - PEG multiplikatori|Salarius Pharma (SLRX) - Narx-foyda va o‘sish multiplikatori|Purple Biotech (PPBT) - Narxning foydaga va o‘sish sur’atiga nisbati|AONC - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|BGNE (BeiGene) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Checkpoint Therapeutics Inc. (CKPT)|PEG multiplikatori ELEV|PEG multiplikatori icadmed.com (ICAD)|PEG multiplikatori IKNA (Ikena Oncology)|NTBL: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIRX - Narxning foydaga va o‘sish sur’atiga nisbati|MOR: Narxning foydaga va o‘sish sur’atiga nisbati|NAYA: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Ascentage
